State regulators crafting crackdown on fake and diverted drugs

01/9/2004 | Wall Street Journal, The

The National Association of Boards of Pharmacy is nearing completion of state guidelines designed to oversee pharmaceutical wholesalers and stop counterfeit and diverted medicines. The plan, now being finalized, likely would require background checks for those seeking licenses as wholesalers and stricter paperwork requirements on a drug's origin.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD